TG Therapeutics (TGTX) Ownership - Who Owns TG Therapeutics?

2,128 Followers

TG Therapeutics (TGTX) Ownership Overview

7.54% Insiders

18.38% Mutual Funds

12.55% Other Institutional Investors

24.56% ETFs

36.96% Public Companies and

Individual Investors

The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. Approximately 55.50% of the company’s stock is owned by Institutional Investors, 7.54% is owned by Insiders, and 36.96% is owned by Public Companies and Individual Investors.

The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. Approximately 30.94% of the company’s stock is owned by Institutional Investors, 7.54% is owned by Insiders, and 24.56% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Nov 25, 2025	Yann Echelard	xxxxxxxxxxxxx	$162850
Sep 12, 2025	Sagar Lonial	xxxxxxxxxxxxx	$672268
Jun 16, 2025	Yann Echelard	xxxxxxxxxxxxx	$369400

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$23768910
Mar 31, 2024	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$10345206

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
15,115,998	Institution	9.87%	587,558,842
13,746,596	Institution	8.98%	534,330,187
11,593,050	Institution	7.57%	450,621,854
9,778,086	Insider	6.39%	380,074,203
5,739,371	Institution	3.75%	223,089,351
1,530,219	Institution	1.00%	59,479,613
1,383,547	Institution	0.90%	53,778,472
1,369,978	Institution	0.89%	53,251,045
1,303,280	Institution	0.85%	50,658,494
1,278,480	Institution	0.84%	49,694,518

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
11,593,050	Institution	7.57%	450,621,854
1,530,219	Institution	1.00%	59,479,613
1,383,547	Institution	0.90%	53,778,472
1,369,978	Institution	0.89%	53,251,045
1,303,280	Institution	0.85%	50,658,494
1,278,480	Institution	0.84%	49,694,518
1,160,000	Institution	0.76%	45,089,200
933,712	Institution	0.61%	36,293,385
879,130	Institution	0.57%	34,171,783
864,254	Institution	0.56%	33,593,553

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core S&P Small Cap ETF	8,291,918	Institution	5.42%	352,738,192
Vanguard Total Stock Market ETF	4,820,157	Institution	3.15%	160,125,616
Vanguard Small-Cap ETF	3,482,569	Institution	2.27%	115,690,942
iShares Russell 2000 ETF	3,387,905	Institution	2.21%	144,121,479
SPDR S&P BIOTECH ETF	3,343,079	Institution	2.18%	144,220,428
Vanguard Small-Cap Growth ETF	1,951,285	Institution	1.27%	64,821,688
Vanguard Extended Market ETF	1,520,364	Institution	0.99%	50,506,492
SPDR Portfolio S&P 600 Small Cap ETF	1,242,142	Institution	0.81%	48,741,652
iShares Russell 2000 Growth ETF	1,201,154	Institution	0.78%	51,097,091
iShares S&P Small-Cap 600 Growth ETF	1,196,957	Institution	0.78%	50,918,551

FAQ

Who Owns TG Therapeutics (TGTX)?

According to the latest TipRanks data, approximately 12.55% of the company's stock is held by institutional investors, 7.54% is held by insiders, and 36.96% is held by retail investors.

What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 12.55% of TG Therapeutics (TGTX) stock is held by institutional investors.

What percentage of TG Therapeutics (TGTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 36.96% of TG Therapeutics (TGTX) stock is held by retail investors.

Who owns the most shares of TG Therapeutics (TGTX)?

iShares owns the most shares of TG Therapeutics (TGTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.